Cystic fibrosis

RALEIGH-DURHAM, N.C , Nov. 01, 2021 (GLOBE NEWSWIRE) -- Aceragen, Inc., a biopharmaceutical company focused on advancing transformational therapeutics for rare and orphan diseases, today…

YONKERS, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct…

Los Angeles, CA, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is…

A three-drug combination for a certain form of cystic fibrosis (CF) not addressed with other…

Alongside the TRIKAFTA trial for patients 12 and older, the team led by Edith Zemanick, MD, pediatric pulmonologist, a principal investigator of the study and associate professor of…

Mandana Emamzadeh, PhD, Pharma Analyst at GlobalData, comments: "As there are very few promising pipeline agents in late-stage development for CF, numerous opportunities will remain for…

Los Angeles, CA, June 21, 2021 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is…

Cystic fibrosis is a disorder that thickens up body fluids and causes blockage of tubes and ducts of the body. It is an that occurs due to mutations in a gene called the cystic fibrosis…